132 related articles for article (PubMed ID: 32445249)
1. How did we get here? Short history of COVID-19 and other coronavirus-related epidemics.
Lango MN
Head Neck; 2020 Jul; 42(7):1535-1538. PubMed ID: 32445249
[TBL] [Abstract][Full Text] [Related]
2. Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.
Hon KL; Leung KKY; Leung AKC; Sridhar S; Qian S; Lee SL; Colin AA
Pediatr Pulmonol; 2020 Jul; 55(7):1584-1591. PubMed ID: 32483934
[TBL] [Abstract][Full Text] [Related]
3. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses
Nat Microbiol; 2020 Apr; 5(4):536-544. PubMed ID: 32123347
[TBL] [Abstract][Full Text] [Related]
4. Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2.
Wang YT; Landeras-Bueno S; Hsieh LE; Terada Y; Kim K; Ley K; Shresta S; Saphire EO; Regla-Nava JA
Trends Microbiol; 2020 Aug; 28(8):605-618. PubMed ID: 32507543
[TBL] [Abstract][Full Text] [Related]
5. A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual.
Caccuri F; Zani A; Messali S; Giovanetti M; Bugatti A; Campisi G; Filippini F; Scaltriti E; Ciccozzi M; Fiorentini S; Caruso A
J Transl Med; 2020 Sep; 18(1):362. PubMed ID: 32967693
[TBL] [Abstract][Full Text] [Related]
6. Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type.
Biswas NK; Majumder PP
Indian J Med Res; 2020 May; 151(5):450-458. PubMed ID: 32474553
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays.
Hyseni I; Molesti E; Benincasa L; Piu P; Casa E; Temperton NJ; Manenti A; Montomoli E
Viruses; 2020 Sep; 12(9):. PubMed ID: 32927639
[TBL] [Abstract][Full Text] [Related]
8. Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak.
Kozlovskaya L; Piniaeva A; Ignatyev G; Selivanov A; Shishova A; Kovpak A; Gordeychuk I; Ivin Y; Berestovskaya A; Prokhortchouk E; Protsenko D; Rychev M; Ishmukhametov A
Int J Infect Dis; 2020 Oct; 99():40-46. PubMed ID: 32721529
[TBL] [Abstract][Full Text] [Related]
9. Response to the COVID-19 Epidemic: The Chinese Experience and Implications for Other Countries.
Liu W; Yue XG; Tchounwou PB
Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32235413
[TBL] [Abstract][Full Text] [Related]
10. Modeling the role of asymptomatics in infection spread with application to SARS-CoV-2.
Dobrovolny HM
PLoS One; 2020; 15(8):e0236976. PubMed ID: 32776963
[TBL] [Abstract][Full Text] [Related]
11. Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward.
Shook-Sa BE; Boyce RM; Aiello AE
J Infect Dis; 2020 Sep; 222(7):1086-1089. PubMed ID: 32750135
[TBL] [Abstract][Full Text] [Related]
12. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.
Korber B; Fischer WM; Gnanakaran S; Yoon H; Theiler J; Abfalterer W; Hengartner N; Giorgi EE; Bhattacharya T; Foley B; Hastie KM; Parker MD; Partridge DG; Evans CM; Freeman TM; de Silva TI; ; McDanal C; Perez LG; Tang H; Moon-Walker A; Whelan SP; LaBranche CC; Saphire EO; Montefiori DC
Cell; 2020 Aug; 182(4):812-827.e19. PubMed ID: 32697968
[TBL] [Abstract][Full Text] [Related]
13. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV.
Zheng M; Song L
Cell Mol Immunol; 2020 May; 17(5):536-538. PubMed ID: 32132669
[No Abstract] [Full Text] [Related]
14. COVID-19, Virology and Geroscience: A Perspective.
Vellas C; Delobel P; de Souto Barreto P; Izopet J
J Nutr Health Aging; 2020; 24(7):685-691. PubMed ID: 32744561
[TBL] [Abstract][Full Text] [Related]
15. Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems.
Silva SJRD; Germano Mendes RP; Alves da Silva CT; Lorusso A; Kohl A; Pena L
J Gen Virol; 2020 Oct; 101(10):1021-1024. PubMed ID: 32579100
[TBL] [Abstract][Full Text] [Related]
16. Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China.
Liao X; Wang B; Kang Y
Intensive Care Med; 2020 Feb; 46(2):357-360. PubMed ID: 32025779
[No Abstract] [Full Text] [Related]
17. Predicting the Epidemiological Outbreak of the Coronavirus Disease 2019 (COVID-19) in Saudi Arabia.
Alboaneen D; Pranggono B; Alshammari D; Alqahtani N; Alyaffer R
Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32630363
[TBL] [Abstract][Full Text] [Related]
18. A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis.
Mavian C; Marini S; Prosperi M; Salemi M
JMIR Public Health Surveill; 2020 Jun; 6(2):e19170. PubMed ID: 32412415
[TBL] [Abstract][Full Text] [Related]
19. Simulating phase transitions and control measures for network epidemics caused by infections with presymptomatic, asymptomatic, and symptomatic stages.
Braun B; Taraktaş B; Beckage B; Molofsky J
PLoS One; 2020; 15(9):e0238412. PubMed ID: 32911518
[TBL] [Abstract][Full Text] [Related]
20. Asymptotic estimates of SARS-CoV-2 infection counts and their sensitivity to stochastic perturbation.
Faranda D; Castillo IP; Hulme O; Jezequel A; Lamb JSW; Sato Y; Thompson EL
Chaos; 2020 May; 30(5):051107. PubMed ID: 32491888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
